论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
补阳益胃汤调节肠道菌群治疗胃癌的研究进展
Received 15 September 2024
Accepted for publication 26 November 2024
Published 23 December 2024 Volume 2024:16 Pages 1863—1869
DOI https://doi.org/10.2147/CMAR.S496404
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Seema Singh
Yu Li,1 Manya Wang,2 Huixie Zhao3
1Oncology Department, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, People’s Republic of China; 2Department of Traditional Chinese Medicine, Shanghai Pudong New Area Nanhui Xincheng Community Health Service Center, Pudong New Area, Shanghai, People’s Republic of China; 3Department of Traditional Chinese Medicine, Shijiazhuang TCM Hospital, Shijiazhuang, People’s Republic of China
Correspondence: Manya Wang, Email wangmanya@126.com
Abstract: Intestinal flora is a complex micro-ecosystem in human body, which is called the second genome of human body. Intestinal flora imbalance plays an important role in the occurrence and development of gastric cancer through circulation, metabolism and immunity. Gastric cancer is associated with dysbacteriosis. Traditional Chinese medicine (TCM) compounds in Buyang Yiwei Decoction can reduce the clinical signs and symptoms of gastric cancer by regulating intestinal microbiota, alleviate the adverse reactions of gastric cancer after radiotherapy and chemotherapy, and improve the quality of life of patients. This article reviews whether Buyang Yiwei Decoction can reduce the risk of gastric cancer or play a therapeutic role in gastric cancer by improving the intestinal microbiota.
Keywords: traditional Chinese medicine, gastric cancer, intestinal microbiota, treatment